Free Trial
NASDAQ:HSAQ

Health Sciences Acquisitions Co. 2 (HSAQ) Stock Price, News & Analysis

Health Sciences Acquisitions Co. 2 logo
$5.28 +0.11 (+2.13%)
(As of 11/20/2024 ET)

About Health Sciences Acquisitions Co. 2 Stock (NASDAQ:HSAQ)

Key Stats

Today's Range
$5.06
$5.28
50-Day Range
$4.61
$13.31
52-Week Range
$9.41
$13.80
Volume
33,150 shs
Average Volume
205,918 shs
Market Capitalization
$59.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.

Receive HSAQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Health Sciences Acquisitions Co. 2 and its competitors with MarketBeat's FREE daily newsletter.

HSAQ Stock News Headlines

New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar
As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.
Quest Completes Acquisition Of Select Laboratory Assets From Allina Health
See More Headlines

HSAQ Stock Analysis - Frequently Asked Questions

Health Sciences Acquisitions Co. 2's stock was trading at $9.13 at the beginning of 2024. Since then, HSAQ shares have decreased by 42.2% and is now trading at $5.28.
View the best growth stocks for 2024 here
.

Health Sciences Acquisitions Co. 2 (HSAQ) raised $139 million in an initial public offering on Tuesday, August 4th 2020. The company issued 13,900,000 shares at a price of $10.00 per share. Chardan and Barclays served as the underwriters for the IPO.

Shares of HSAQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Health Sciences Acquisitions Co. 2 investors own include Churchill Capital Corp IV (CCIV), FS Development (FSDC), Gores Holdings IV (GHIV), Gores Holdings V (GRSVU), Holicity (HOLUU), Kismet Acquisition One (KSMTU) and Lionheart Acquisition Co. II (LCAPU).

Company Calendar

Today
11/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:HSAQ
Web
N/A
Phone
N/A
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Net Income
$-380,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.62) per share

Miscellaneous

Free Float
8,757,000
Market Cap
$59.20 million
Optionable
Not Optionable
Beta
0.09
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:HSAQ) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners